Clinical trial Recruiting at 2 sites Interventional Ages 18 to 40 Women only

Vitamin D's effect on ovulation in women with PCOS

Official title: A Randomized Double-blind Controlled Trial on the Effect of Vitamin D on Ovulation Rate of Women With Polycystic Ovary Syndrome

Run by The University of Hong Kong · NCT04650880 · Data updated 2026-11-12

This study tests if taking vitamin D can help women with PCOS have more regular ovulation.

Quick facts

Study typeInterventional
Ages18 Years to 40 Years
SexWomen only
Enrollment220 (estimated)
SponsorThe University of Hong Kong
Academic / other
Locations3 sites (Hong Kong and 2 other locations)
StatusRecruiting
StartedJanuary 26, 2021
Main results expectedDecember 31, 2024
Study endsDecember 31, 2026
Registry record updatedMay 14, 2024
Trial IDNCT04650880 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are premenopausal women aged 18-40 with irregular menstrual cycles and diagnosed with PCOS according to the Rotterdam criteria.

Probably not a fit

Patients currently using hormonal medications or those with conditions affecting vitamin D metabolism may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the impact of vitamin D supplementation on the ovulation rate in women diagnosed with polycystic ovary syndrome (PCOS). It is a randomized double-blind controlled trial where participants will receive either vitamin D or a placebo over a one-year period. The study aims to determine if vitamin D can improve ovulation rates either spontaneously or in conjunction with an oral ovulation induction agent. Participants will be monitored for reproductive, endocrine, and metabolic outcomes throughout the trial.

Why it matters

Potential benefit: If successful, this study could provide a new, non-invasive treatment option to improve ovulation rates in women with PCOS.

How similar studies have gone: While the approach of using vitamin D for ovulation in PCOS is promising, it remains relatively novel and has not been extensively tested in similar studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Premenopausal
* Aged 18-40 years
* Irregular long menstrual cycles (\>35 days)
* PCOS according to the Rotterdam criteria
* Agree for transvaginal ultrasound

Exclusion Criteria:

* Use of hormonal medication (including contraception) within 3 months prior to study inclusion, except the use of a progestogen to induce withdrawal bleeding every 3 months
* History of any medical condition or medications that may predispose to vitamin D sensitivity, altered vitamin D metabolism and/ or hypercalcemia, including active tuberculosis or current therapy for tuberculosis, sarcoidosis, history of renal/ ureteral stones, parathyroid disease, renal or liver failure or current use of anti-convulsants
* Use of insulin-sensitizing drugs, lipid lowering drugs or anti-hypertensive
* Anticipated to use the above medications in the coming one year
* Known type 2 diabetes mellitus
* Refusal to join the study
* Abnormal blood calcium level

For those on supplements, we asked them to stop their own supplements.

Where it's running

  • Kwong Wah Hospital
    Hong Kong, Hong Kong
    Recruiting
  • Queen Mary Hospital, University of Hong Kong
    Hong Kong, Hong Kong
    Recruiting
  • Princess Margaret Hospital
    Hong Kong, Hong Kong
    Not yet recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.